BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34391411)

  • 21. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
    Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
    Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
    Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
    Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
    Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
    Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3.
    Xia M; Yao L; Zhang Q; Wang F; Mei H; Guo X; Huang W
    Oncotarget; 2017 Mar; 8(12):19795-19802. PubMed ID: 28177890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
    Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
    Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of histone demethylase KDM2A enhanced the adipogenic and chondrogenic differentiation potentials of stem cells from apical papilla.
    Dong R; Yao R; Du J; Wang S; Fan Z
    Exp Cell Res; 2013 Nov; 319(18):2874-82. PubMed ID: 23872478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
    De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
    Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell.
    Xu WH; Liang DY; Wang Q; Shen J; Liu QH; Peng YB
    Mol Cell Biochem; 2019 Jun; 456(1-2):95-104. PubMed ID: 30604066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
    Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
    Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
    Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
    Li J; Sheng C; Li W; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
    He D; Yu Z; Liu S; Dai H; Xu Q; Li F
    Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.
    Guo Z; Liu J; Zhang L; Su B; Xing Y; He Q; Ci W; Li X; Zhou L
    Tumour Biol; 2015 Feb; 36(2):1251-9. PubMed ID: 25344677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA LINC01278 accelerates colorectal cancer progression via miR-134-5p/KDM2A axis.
    Xi C; Ye NY; Wang YB
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10526-10534. PubMed ID: 33155208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth.
    Chen JY; Li CF; Lai YS; Hung WC
    Br J Cancer; 2021 Jan; 124(2):484-493. PubMed ID: 33024266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.